Syntis Bio
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $29M
Investors
- 10
About Syntis Bio
Syntis Bio, Inc.Syntis Bio, Inc. is engaged in the development of oral therapies that utilize the small intestine's biology to address healthcare issues.Syntis Bio specializes in developing innovative oral therapies that leverage the unique biology of the small intestine to address pivotal healthcare challenges, particularly in the realms of obesity, diabetes, and rare genetic disorders. The company's primary product offerings focus on drug candidates designed for metabolic control, digestion, and enhanced drug absorption, particularly targeting obesity.Syntis Bio's revenue model is based on partnerships and direct sales of its oral therapies to healthcare providers and institutions. Engaging in B2B transactions, the company collaborates with hospitals and clinics to administer its drug candidates.00 mn from The National Institutes of Health, received in July 2025, to advance the SYNT platform, particularly the SYNT-101 obesity program. The company is also targeting expansion into additional markets within North America and Europe to reach more patients facing obesity and related health issues. This strategic growth will facilitate the introduction of new products and enhance the accessibility of its therapies.
Who invested in Syntis Bio
10 investors across 2 rounds
See all investors in Syntis Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syntis Bio
Who invested in Syntis Bio?
Syntis Bio has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syntis Bio raised?
Syntis Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Syntis Bio last raise money?
Syntis Bio's most recent round on record is a Series A, in Jun 2025.
What does Syntis Bio do?
Syntis Bio is a biotechnology company.
Where is Syntis Bio headquartered?
Syntis Bio is headquartered in Boston, US.
Which VCs invest in companies like Syntis Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Syntis Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Syntis Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.